SK
Sanjay Kumar
About Sanjay Kumar
Data last updated:
Sanjay Kumar is a Director at Acme Therapeutics (I) Private Limited (since 2019). The companies operate in Pharma. Acme Therapeutics (I) Private Limited reported revenue of ₹14.81 Cr (FY 2025). Earlier, Sanjay Kumar was a Managing Director at Allegro Remedies Private Limited (2013–2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Oct 2019 | 2001 | ₹14.81 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 17 Dec 2013 | 2013 | ₹1.4 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjay Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Banshidhar Kanhaiyalal | 00258727 | Acme Therapeutics (I) Private Limited | Director |
| Gopal Krishna | 01833359 | Acme Therapeutics (I) Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Kumar
Sanjay Kumar currently holds 1 directorship: Acme Therapeutics (I) Private Limited (Director, since 21 Oct 2019, revenue ₹14.81 Cr (FY 2025)).
Sanjay Kumar was first appointed on 17 Dec 2013 as Managing Director at Allegro Remedies Private Limited. The most recent appointment on record is 21 Oct 2019 at Acme Therapeutics (I) Private Limited.
Sanjay Kumar held 1 earlier board appointment: Allegro Remedies Private Limited (Managing Director, 17 Dec 2013 to 25 Apr 2017).
The current boards of Sanjay Kumar's companies include Banshidhar Kanhaiyalal (Acme Therapeutics (I) Private Limited), Gopal Krishna (Acme Therapeutics (I) Private Limited).